93 related articles for article (PubMed ID: 2569698)
1. [Effect of somatostatin and salmon calcitonin on carcinoid syndrome. A clinical case].
Festa V; Garrone C; Vietti Ramus G; Lisa F; Simone P; Scotti M; Cocchis D; Garrone GC
Minerva Chir; 1989 May; 44(9):1429-33. PubMed ID: 2569698
[TBL] [Abstract][Full Text] [Related]
2. Treatment of the carcinoid syndrome with somatostatin, salmon calcitonin, or octreotide.
Antonelli A; Gambuzza C; Bertoni F; Baschieri L
Clin Ther; 1992; 14(2):178-84. PubMed ID: 1377097
[TBL] [Abstract][Full Text] [Related]
3. [Effects of the administration of somatostatin 14 in the carcinoid syndrome. Clinical and biological study of 2 cases].
Guillard JF; Galmiche JP; Chayvialle JA; Kremer M; Comoy E; Lerebours E; Charbonnel B; Colin R
Gastroenterol Clin Biol; 1983 Dec; 7(12):1016-22. PubMed ID: 6141119
[TBL] [Abstract][Full Text] [Related]
4. Successful symptomatic treatment of malignant carcinoid syndrome with the somatostatin analogue SMS 201-995.
van Houten AA; Nortier JW; Vendrik CP
Neth J Med; 1988 Apr; 32(3-4):194-8. PubMed ID: 2896307
[No Abstract] [Full Text] [Related]
5. Effects of somatostatin infusion in four patients with malignant carcinoid syndrome.
Quatrini M; Basilisco G; Conte D; Bozzani A; Bardella MT; Bianchi PA
Am J Gastroenterol; 1983 Mar; 78(3):149-51. PubMed ID: 6187212
[TBL] [Abstract][Full Text] [Related]
6. Effects of somatostatin on bronchial constriction in a patient with carcinoid syndrome.
Klapdor R
N Engl J Med; 1980 Aug; 303(8):464. PubMed ID: 6104790
[No Abstract] [Full Text] [Related]
7. [Somatostatin analogs in the treatment of carcinoid syndrome: a case report and review of literature].
Junik R; Kamińska A; Kamiński M; Ruprecht Z
Pol Arch Med Wewn; 2003 Sep; 110(3):997-1001. PubMed ID: 14699693
[TBL] [Abstract][Full Text] [Related]
8. Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome.
Davis GR; Camp RC; Raskin P; Krejs GJ
Gastroenterology; 1980 Feb; 78(2):346-9. PubMed ID: 7350058
[TBL] [Abstract][Full Text] [Related]
9. Rapid reversal of carcinoid crisis with a somatostatin analogue.
Kvols LK; Martin JK; Marsh HM; Moertel CG
N Engl J Med; 1985 Nov; 313(19):1229-30. PubMed ID: 2865675
[No Abstract] [Full Text] [Related]
10. Octreotide treatment of carcinoid hypertensive crisis.
Warner RR; Mani S; Profeta J; Grunstein E
Mt Sinai J Med; 1994 Sep; 61(4):349-55. PubMed ID: 7969229
[TBL] [Abstract][Full Text] [Related]
11. The carcinoid syndrome.
Oates JA
N Engl J Med; 1986 Sep; 315(11):702-4. PubMed ID: 2875390
[No Abstract] [Full Text] [Related]
12. Carcinoid Flush: role of gastrin and somatostatin.
N Engl J Med; 1979 Mar; 300(11):624. PubMed ID: 763277
[No Abstract] [Full Text] [Related]
13. [The effect of somatostatin on bronchial obstruction in carcinoid (author's transl)].
Klapdor R; Lanser K; von Wichert P
Prax Klin Pneumol; 1982 Apr; 36(4):202-5. PubMed ID: 6124963
[No Abstract] [Full Text] [Related]
14. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J
Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271
[TBL] [Abstract][Full Text] [Related]
15. [Carcinoid syndrome with a course of more than 10 years].
Baur X; Bortsch A; Autenrieth G; Jacob K; Neudert J; Schneider B; Werdan K
Internist (Berl); 1988 May; 29(5):347-50. PubMed ID: 2900222
[No Abstract] [Full Text] [Related]
16. Burden of Carcinoid Heart Disease in Patients With Carcinoid Syndrome Initiating Somatostatin Analogues.
Joish VN; Perez-Olle R; Lapuerta P; Dharba S; Zacks J
Clin Ther; 2019 Sep; 41(9):1716-1723.e2. PubMed ID: 31326125
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; Rubin J; O'Connell MJ
Cancer Treat Rep; 1986 Dec; 70(12):1459-60. PubMed ID: 3791259
[No Abstract] [Full Text] [Related]
18. Treatment of malignant carcinoid syndrome with a long-acting somatostatin analogue.
Altman AR; Tschen JA; Rice L
Arch Dermatol; 1989 Mar; 125(3):394-6. PubMed ID: 2923448
[TBL] [Abstract][Full Text] [Related]
19. Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome.
Ahlman H; Ahlund L; Dahlström A; Nilsson O; Skolnik G; Tisell LE; Tylén U
Br J Cancer; 1987 Dec; 56(6):840-2. PubMed ID: 2893640
[No Abstract] [Full Text] [Related]
20. Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management.
Vinik AI; Thompson N; Eckhauser F; Moattari AR
Acta Oncol; 1989; 28(3):389-402. PubMed ID: 2663049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
